<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20030000128A1-20030102-C00001.CDX SYSTEM "US20030000128A1-20030102-C00001.CDX" NDATA CDX>
<!ENTITY US20030000128A1-20030102-C00001.MOL SYSTEM "US20030000128A1-20030102-C00001.MOL" NDATA MOL>
<!ENTITY US20030000128A1-20030102-C00001.TIF SYSTEM "US20030000128A1-20030102-C00001.TIF" NDATA TIF>
<!ENTITY US20030000128A1-20030102-C00002.CDX SYSTEM "US20030000128A1-20030102-C00002.CDX" NDATA CDX>
<!ENTITY US20030000128A1-20030102-C00002.MOL SYSTEM "US20030000128A1-20030102-C00002.MOL" NDATA MOL>
<!ENTITY US20030000128A1-20030102-C00002.TIF SYSTEM "US20030000128A1-20030102-C00002.TIF" NDATA TIF>
<!ENTITY US20030000128A1-20030102-C00003.CDX SYSTEM "US20030000128A1-20030102-C00003.CDX" NDATA CDX>
<!ENTITY US20030000128A1-20030102-C00003.MOL SYSTEM "US20030000128A1-20030102-C00003.MOL" NDATA MOL>
<!ENTITY US20030000128A1-20030102-C00003.TIF SYSTEM "US20030000128A1-20030102-C00003.TIF" NDATA TIF>
<!ENTITY US20030000128A1-20030102-C00004.CDX SYSTEM "US20030000128A1-20030102-C00004.CDX" NDATA CDX>
<!ENTITY US20030000128A1-20030102-C00004.MOL SYSTEM "US20030000128A1-20030102-C00004.MOL" NDATA MOL>
<!ENTITY US20030000128A1-20030102-C00004.TIF SYSTEM "US20030000128A1-20030102-C00004.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20030000128</doc-number>
<kind-code>A1</kind-code>
<document-date>20030102</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>09824141</doc-number>
</application-number>
<application-number-series-code>09</application-number-series-code>
<filing-date>20010402</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>C10L005/00</ipc>
</classification-ipc-primary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>044</class>
<subclass>275000</subclass>
</uspc>
</classification-us-primary>
</classification-us>
<title-of-invention>Candle wax stabilized with oxazolidines</title-of-invention>
</technical-information>
<inventors>
<first-named-inventor>
<name>
<given-name>Mervin</given-name>
<middle-name>G.</middle-name>
<family-name>Wood</family-name>
</name>
<residence>
<residence-us>
<city>Poughquag</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Andrea</given-name>
<middle-name>R.</middle-name>
<family-name>Smith</family-name>
</name>
<residence>
<residence-us>
<city>Wingdale</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Deborah</given-name>
<family-name>DeHessa</family-name>
</name>
<residence>
<residence-us>
<city>Poughkeepsie</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Sai</given-name>
<middle-name>Ping</middle-name>
<family-name>Shum</family-name>
</name>
<residence>
<residence-us>
<city>Jamesburg</city>
<state>NJ</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>CIBA SPECIALTY CHEMICALS CORPORATION</name-1>
<name-2>PATENT DEPARTMENT</name-2>
<address>
<address-1>540 WHITE PLAINS RD</address-1>
<address-2>P O BOX 2005</address-2>
<city>TARRYTOWN</city>
<state>NY</state>
<postalcode>10591-9005</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">White, dyed, dipped, unscented and/or scented candle wax is effectively stabilized against discoloration and fading by the incorporation therein of an oxazolidine in combination with a UV absorber and/or an antioxidant. </paragraph>
</subdoc-abstract>
<subdoc-description>
<summary-of-invention>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> The instant invention pertains to white, dyed, dipped, unscented and/or scented candle wax which is effectively stabilized against discoloration and fading by the incorporation therein of an oxazolidine in combination with a UV absorber and/or an antioxidant. </paragraph>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0002" lvl="0"><number>&lsqb;0002&rsqb;</number> Candles have been known for many centuries going back to the eighth century B.C. The nature of candles is described in Ullmann&apos;s Encyclopedia of Industrial Chemistry, Volume A5 at pages 29-30 where it is seen that candles are made from paraffin, beeswax and stearin as basic materials, and where a host of additives may also be present. </paragraph>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> It is not surprising that with candles and wax becoming increasingly more important attention was paid as to how to stabilize the said materials. At the National Candle Association Meeting in Houston, 1994, R. van der Vennet presented a paper on &ldquo;Antioxidants in Wax&mdash;Replacement of BHT&rdquo; touting the use of Vitamin E (tocopherol) as an antioxidant to prevent the yellowing of wax when oxidized. WO 94/13736 describes the same invention. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> EP 359,488 A3 and EP 133,964 B1 describe stabilized waxes used in cosmetics where the waxes are the same or similar to those used in candles. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> EP 5,922 A1 describes lip cosmetics where the waxes are useful in lipsticks and are related to those useful in candles. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> U.S. Pat. No. 5,879,694 describes in detail transparent gel candles both in composition and structure. The use of BHT as an antioxidant is mentioned. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> At the National Candle Association Technical Meeting on Apr. 16, 1998, F. A. Ballentine et al., presented a paper entitled &ldquo;Inhibiting Color Fading of Dyed Candles with CYASORB&reg; Light Absorbers&rdquo; in which the general theories of thermal oxidation and photodegradation are discussed along with data on the effect of light absorbers on color stability of dyed candle waxes. The light absorbers compared are 4-octyloxy-2-hydroxy-benzophenone UV-531; 4-methoxy-2hydroxybenzophenone UV-9; 2-(2-hydroxy-5-methylphenyl)-2H-benzotriazole UV-5365; 2-(2-hydroxy-5-tert-octylphenyl-2H-benzo-triazole UV-5411 and 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole UV-2337). </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> U.S. Pat. No. 5,964,905 teaches dyed and scented candle gels containing triblock copolymers and a hydrocarbon oil of high flash point. This reference teaches that a light (UV) absorber may be used to improve the shelf stability of the candle color when exposed to visible or ultraviolet light. Two preferred absorbers are ethylhexyl p-methoxycinnamate (PARSOL&reg; MCX, Roche) and 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole (CYASORB&reg; 5411, Cytec). </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> WO 00/22037 teaches the stabilization of solid, shaped and colored wax articles, including candles, using a malonate UV absorber which may optionally contain a hindered amine moiety as part of the malonate compound structure. The wax articles are dyed with a variety of oil soluble dyes and pigments. The samples protected by dimethyl p-methoxy-benzylidinemalonate exhibited better resistance to discoloration that did samples stabilized with selected benzotriazole or benzophenone UV absorbers. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> Japanese Hei 3-278554 teaches that wax crayons (drawing materials) colored by organic pigments can be stabilized by a hindered amine and/or benzotriazole. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> In respect to wax stabilization, the use of selected hindered amines and/or benzotriazole UV absorbers is also known in the prior art as seen in U.S. Pat. Nos. 3,530,084; 4,379,721; 4,616,051 and 5,964,905 and copending applications Ser. Nos. 09/495,495, 09/495,496 and 09/741,583. </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> WO 00/14177 teaches the inhibition of vinyl monomer polymerization using hindered hydroxylamines some of which may contain an oxazolidine moiety. There is no suggestion that any of these compounds would be stabilizers for candle wax. </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> U.S. Pat. Nos. 4,125,518 and 4,104,254 teach that 1-oxa-4-aza-spiro&lsqb;4.5&rsqb;decanes and other oxazolidine molecules are useful light stabilizers for polyolefins such as polypropylene. </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> U.S. Pat. Nos. 5,264,148 and 5,223,174 describe various mono- and bicyclic oxazolidine compounds which have the property of scavenging moisture particularly aimed at efficiently, cost effectively and safely removing water from moisture-curable polyurethane coating systems or any other water-sensitive system where residual water is a problem. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> U.S. Pat. Nos. 3,707,541 and 3,825,555 describe the use of oxazolidine and tetrahydrooxazine compounds as insect repellents. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> U.S. Pat. Nos. 4,017,406, 4,116,643 and 4,369,118 describe oxazoline compounds and amine salts of carboxylate half esters of 1-aza-3,7-dioxabicyclo-&lsqb;3,3,0&rsqb;oct-5-yl methyl alcohols as additives for lubricating oils, gasoline, middle distillate fuels and other oleaginous products. </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> U.S. Pat. No. 5,001,233 teaches the synthesis of hydroxylamines using dioxiranes. Cyclic hydroxylamines having oxazolidine moieties present are disclosed. </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> U.S. Pat. Nos. 5,328,635 and 5,433,891 disclose iminoalcohol-oxazolidine mixtures which are useful as corrosion inhibitors, moisture or formaldehyde scavengers, drying agents and the like. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> WO 98/11181 describes substituted oxazolines, related to oxazolidines, which are antioxidants and antioxidant boosters capable of producing hydroperoxyl radicals. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> WO 99/05108 teaches the inhibition of pulp or paper which contains lignin from yellowing by use inter alia of a substituted oxazolidine or a salt thereof. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> None of these references teach the superior performance provided when the oxazolidine compounds are used in conjunction with a UV absorber and/or antioxidant to stabilize candle wax. </paragraph>
</section>
<section>
<heading lvl="1">OBJECTS OF THE INVENTION </heading>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> The object of the invention is to provide for a white and unscented; white and scented; dyed and unscented; dyed and scented; dipped and unscented; or dipped and scented candle wax stabilized by a combination of an oxazolidine compound with a UV absorber and/or antioxidant. </paragraph>
</section>
<section>
<heading lvl="1">DETAILED DISCLOSURE </heading>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> The instant invention pertains to a composition which comprises </paragraph>
<paragraph id="P-0024" lvl="2"><number>&lsqb;0024&rsqb;</number> (a) candle wax which is white and unscented; white and scented; dyed and unscented; dyed and scented; dipped and unscented; or dipped and scented, and </paragraph>
<paragraph id="P-0025" lvl="2"><number>&lsqb;0025&rsqb;</number> (b) an effective stabilizing amount of a combination of </paragraph>
<paragraph id="P-0026" lvl="3"><number>&lsqb;0026&rsqb;</number> (i) an oxazolidine compound containing a moiety of generic formula I, II or III  
<chemistry-cwu id="CHEM-US-00001">
<number>1</number>
<image id="EMI-C00001" he="281.0619" wi="169.22115" file="US20030000128A1-20030102-C00001.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00001" file="US20030000128A1-20030102-C00001.CDX"/>
<chemistry-mol-file id="CHEMMOL-00001" file="US20030000128A1-20030102-C00001.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0027" lvl="3"><number>&lsqb;0027&rsqb;</number> (ii) a UV absorber or an antioxidant, or a UV absorber and an antioxidant </paragraph>
<paragraph id="P-0028" lvl="2"><number>&lsqb;0028&rsqb;</number> wherein the ratio by weight of (i) to (ii) is from 10:1 to 1:10. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> In another embodiment of the instant invention, the oxazolidine compound of component (b)(i) is a compound of formula Ia, IIa or IIIa  
<chemistry-cwu id="CHEM-US-00002">
<number>2</number>
<image id="EMI-C00002" he="251.8047" wi="175.23135" file="US20030000128A1-20030102-C00002.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00002" file="US20030000128A1-20030102-C00002.CDX"/>
<chemistry-mol-file id="CHEMMOL-00002" file="US20030000128A1-20030102-C00002.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0030" lvl="7"><number>&lsqb;0030&rsqb;</number> where </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> R<highlight><subscript>1</subscript></highlight>, R<highlight><subscript>2</subscript></highlight>, R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>are independently alkyl of 1 to 12 carbon atoms, aryl of 6 to 10 carbon atoms or said alkyl substituted by one or two hydroxyl groups; or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together or R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>together are tetramethylene, pentamethylene or pentamethylene substituted by methyl; </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> R<highlight><subscript>5 </subscript></highlight>is hydrogen, oxyl, hydroxyl, aralkyl of 7 to 15 carbon atoms, alkoxy of 1 to 24 carbon atoms, alkyl of 1 to 42 carbon atoms, said alkyl substituted by one or two hydroxyl groups, said alkyl substituted by alkylcarbonyloxy of 2 to 18 carbon atoms, or said alkyl interrupted by one to twenty oxygen atoms and substituted by one hydroxyl, by alkylcarbonyloxy of 2 to 18 carbon atoms or by 4-hydroxy-3,5-di-tert-butylbenzoyloxy, or R<highlight><subscript>5 </subscript></highlight>is &mdash;CO&mdash;C<highlight><subscript>n</subscript></highlight>H<highlight><subscript>2n&plus;1</subscript></highlight>where n is 1 to 17, and </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> R<highlight><subscript>6 </subscript></highlight>is alkyl of 1 to 12 carbon atoms, aralkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms or said alkyl substituted by one or two hydroxyl groups. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> In another embodiment of the invention R<highlight><subscript>1</subscript></highlight>, R<highlight><subscript>2</subscript></highlight>, R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>are each methyl, or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together and R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>together are pentamethylene. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> Specific oxazolidine compounds of formula Ia, IIa or IIIa which are useful in the instant invention include </paragraph>
<paragraph id="P-0036" lvl="2"><number>&lsqb;0036&rsqb;</number> (a) 3,3-dimethyl-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, </paragraph>
<paragraph id="P-0037" lvl="2"><number>&lsqb;0037&rsqb;</number> (b) 2,2,4,4-tetramethyl-1,3-oxazolidine, </paragraph>
<paragraph id="P-0038" lvl="2"><number>&lsqb;0038&rsqb;</number> (c) 2,2,11,11-tetramethyl-3,9-dioxa-dispiro(4.2.4.2&rsqb;tetradecane, </paragraph>
<paragraph id="P-0039" lvl="2"><number>&lsqb;0039&rsqb;</number> (d) 3,3-dimethyl-1-oxa-4-oxyl-4-azaspiro&lsqb;4.5&rsqb;decane, </paragraph>
<paragraph id="P-0040" lvl="2"><number>&lsqb;0040&rsqb;</number> (e) 3,3-dimethyl-1-oxa-4-hydroxy-4-azaspiro&lsqb;4.5&rsqb;decane, </paragraph>
<paragraph id="P-0041" lvl="2"><number>&lsqb;0041&rsqb;</number> (f) 3,3-dimethylol-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, </paragraph>
<paragraph id="P-0042" lvl="2"><number>&lsqb;0042&rsqb;</number> (g) 2,3,3-trimethyl-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, </paragraph>
<paragraph id="P-0043" lvl="2"><number>&lsqb;0043&rsqb;</number> (h) 3,3-di(2-hydroxyethyl)-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, </paragraph>
<paragraph id="P-0044" lvl="2"><number>&lsqb;0044&rsqb;</number> (i) 4-ethyl-2-isopropyloxazolidine, </paragraph>
<paragraph id="P-0045" lvl="2"><number>&lsqb;0045&rsqb;</number> (j) 1-aza-3,7-dioxa-2,8-diisopropyl-5-ethylbicyclo&lsqb;3.3.0&rsqb;octane, </paragraph>
<paragraph id="P-0046" lvl="2"><number>&lsqb;0046&rsqb;</number> (k) 3-acetyl-4,4-dimethyl-2-(3-amyl)oxazolidine, </paragraph>
<paragraph id="P-0047" lvl="2"><number>&lsqb;0047&rsqb;</number> (l) 3-acetyl-4-ethyl-2-phenyloxazolidine, </paragraph>
<paragraph id="P-0048" lvl="2"><number>&lsqb;0048&rsqb;</number> (m) N-(2-hydroxyethyl)-2,2&prime;-diethyl-4,4&prime;-dimethyl-1,3-oxazolidine, </paragraph>
<paragraph id="P-0049" lvl="2"><number>&lsqb;0049&rsqb;</number> (n) 1-aza-3,7-dioxa-2,8-diphenyl-5-methylolbicyclo&lsqb;3.3.0&rsqb;octane, or </paragraph>
<paragraph id="P-0050" lvl="2"><number>&lsqb;0050&rsqb;</number> (o) 1-aza-3,7-dioxa-2,8-di-n-propyl-5-methylolbicyclo&lsqb;3.3.0&rsqb;octane. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> Another embodiment of the instant invention is where the oxazolidine compound of component (b)(i) is </paragraph>
<paragraph id="P-0052" lvl="2"><number>&lsqb;0052&rsqb;</number> (a) 3,3-dimethyl-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, </paragraph>
<paragraph id="P-0053" lvl="2"><number>&lsqb;0053&rsqb;</number> (b) 2,2,4,4-tetramethyl-1,3-oxazolidine, </paragraph>
<paragraph id="P-0054" lvl="2"><number>&lsqb;0054&rsqb;</number> (c) 2,2,11,11-tetramethyl-3,9-dioxa-dispiro(4.2.4.2&rsqb;tetradecane, </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> In another embodiment of the invention, the ratio by weight of (i) to (ii) is from 4:1 to 1:4. </paragraph>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> Another embodiment of the invention is where the ratio by weight of (i) to (ii) is from 2:1 to 1:2. </paragraph>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> In still another embodiment of the invention, the effective amount of the UV absorber plus the oxazolidine compound in the candle wax is 0.01 to 10% by weight based on the wax. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> Another embodiment of the invention is where the effective amount of the UV absorber plus oxazolidine in the candle wax is 0.1 to 2% by weight based on the wax. </paragraph>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> Another embodiments of the invention is where the effective amount of the UV absorber plus oxazolidine in the candle wax is 0.1 to 0.5% by weight based on the wax. </paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> The UV absorber of component (ii) is a benzotriazole, a benzophenone, an &agr;-cyanoacrylate, an oxanilide, an s-triazine, a cinnamate, a malonate, a benzoate or a salicylate, or a mixture thereof. </paragraph>
<paragraph id="P-0061" lvl="0"><number>&lsqb;0061&rsqb;</number> In another embodiment of the invention, the UV absorber is a benzotriazole, a benzophenone or an s-triazine. </paragraph>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> Examples of the UV absorbers useful in the instant invention are </paragraph>
<paragraph id="P-0063" lvl="2"><number>&lsqb;0063&rsqb;</number> (a) 4-octyloxy-2-hydroxybenzophenone; </paragraph>
<paragraph id="P-0064" lvl="2"><number>&lsqb;0064&rsqb;</number> (b) 4-methoxy-2-hydroxybenzophenone; </paragraph>
<paragraph id="P-0065" lvl="2"><number>&lsqb;0065&rsqb;</number> (c) 2-(2-hydroxy-5-methylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0066" lvl="2"><number>&lsqb;0066&rsqb;</number> (d) 2-(2-hydroxy-5-tert-octylphenyl-2H-benzotriazole; </paragraph>
<paragraph id="P-0067" lvl="2"><number>&lsqb;0067&rsqb;</number> (e) 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0068" lvl="2"><number>&lsqb;0068&rsqb;</number> (f) octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate; </paragraph>
<paragraph id="P-0069" lvl="2"><number>&lsqb;0069&rsqb;</number> (g) 2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0070" lvl="2"><number>&lsqb;0070&rsqb;</number> (h) 2-(2-hydroxy-5-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0071" lvl="2"><number>&lsqb;0071&rsqb;</number> (i) 5-chloro-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0072" lvl="2"><number>&lsqb;0072&rsqb;</number> (j) 5-chloro-2-(2-hydroxy-3-tert-butyl-5-methylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0073" lvl="2"><number>&lsqb;0073&rsqb;</number> (k) 2-(2-hydroxy-3-sec-butyl-5-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0074" lvl="2"><number>&lsqb;0074&rsqb;</number> (l) 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0075" lvl="2"><number>&lsqb;0075&rsqb;</number> (m) 2-(2-hydroxy-3-dodecyl-5-methylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0076" lvl="2"><number>&lsqb;0076&rsqb;</number> (n) 2-&lsqb;2-hydroxy-3,5-di(&agr;,&agr;-dimethylbenzyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0077" lvl="2"><number>&lsqb;0077&rsqb;</number> (o) 2-&lsqb;2-hydroxy-3-(&agr;,&agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0078" lvl="2"><number>&lsqb;0078&rsqb;</number> (p) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy)carbonyl)-ethyl&rsqb;phenyl&rcub;-2H-benzotriazole; </paragraph>
<paragraph id="P-0079" lvl="2"><number>&lsqb;0079&rsqb;</number> (q) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(octyloxy)carbonyl)ethyl&rsqb;phenyl&rcub;-2H-benzo-triazole. </paragraph>
<paragraph id="P-0080" lvl="2"><number>&lsqb;0080&rsqb;</number> (r) 2-ethylhexyl p-methoxycinnamate; </paragraph>
<paragraph id="P-0081" lvl="2"><number>&lsqb;0081&rsqb;</number> (s) 4-methoxy-2,2&prime;-dihydroxybenzophenone; </paragraph>
<paragraph id="P-0082" lvl="2"><number>&lsqb;0082&rsqb;</number> (t) 4,4&prime;dimethoxy-2,2&prime;-dihydroxybenzophenone; </paragraph>
<paragraph id="P-0083" lvl="2"><number>&lsqb;0083&rsqb;</number> (u) 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine; </paragraph>
<paragraph id="P-0084" lvl="2"><number>&lsqb;0084&rsqb;</number> (v) 2,4-diphenyl-6-(2-hydroxy-4-hexyloxyphenyl)-s-triazine; </paragraph>
<paragraph id="P-0085" lvl="2"><number>&lsqb;0085&rsqb;</number> (w) 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxy-propoxy)phenyl&rsqb;-s-triazine; </paragraph>
<paragraph id="P-0086" lvl="2"><number>&lsqb;0086&rsqb;</number> (x) 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxy-propoxy)-5-&agr;-cumylphenyl&rsqb;-s-triazine; </paragraph>
<paragraph id="P-0087" lvl="2"><number>&lsqb;0087&rsqb;</number> (y) reaction product of 2,4,6-tris(2,4-dihydroxyphenyl)-s-triazine with octyl &agr;-haloacetate; or </paragraph>
<paragraph id="P-0088" lvl="2"><number>&lsqb;0088&rsqb;</number> (z) the mixture of 3,3;3,5;5,5-methylene-bis&lsqb;2,4-bis(2,4-dimethyl-phenyl)&rsqb;-6-&lsqb;2-hydroxy-4-(3-butyloxy-2-hydroxypropoxyphenyl)&rsqb;-s-triazine. </paragraph>
<paragraph id="P-0089" lvl="0"><number>&lsqb;0089&rsqb;</number> Still other examples of UV absorbers useful in the instant invention are </paragraph>
<paragraph id="P-0090" lvl="2"><number>&lsqb;0090&rsqb;</number> (a) 4-octyloxy-2-hydroxybenzophenone; </paragraph>
<paragraph id="P-0091" lvl="2"><number>&lsqb;0091&rsqb;</number> (b) 4-methoxy-2-hydroxybenzophenone; </paragraph>
<paragraph id="P-0092" lvl="2"><number>&lsqb;0092&rsqb;</number> (d) 2-(2-hydroxy-5-tert-octylphenyl-2H-benzotriazole; </paragraph>
<paragraph id="P-0093" lvl="2"><number>&lsqb;0093&rsqb;</number> (o) 2-&lsqb;2-hydroxy-3-(&agr;,&agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0094" lvl="2"><number>&lsqb;0094&rsqb;</number> (p) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy)carbonyl)-ethyl&rsqb;phenyl&rcub;-2H-benzotriazole; </paragraph>
<paragraph id="P-0095" lvl="2"><number>&lsqb;0095&rsqb;</number> (q) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(octyloxy)carbonyl)ethyl&rsqb;phenyl&rcub;-2H-benzo-triazole; </paragraph>
<paragraph id="P-0096" lvl="2"><number>&lsqb;0096&rsqb;</number> (y) reaction product of 2,4,6-tris(2,4-dihydroxyphenyl)-s-triazine with octyl &agr;-haloacetate; or </paragraph>
<paragraph id="P-0097" lvl="2"><number>&lsqb;0097&rsqb;</number> (z) the mixture of 3,3;3,5;5,5-methylene-bis&lsqb;2,4-bis(2,4-dimethyl-phenyl)&rsqb;-6-&lsqb;2-hydroxy-4-(3-butyloxy-2-hydroxypropoxyphenyl)&rsqb;-s-triazine. </paragraph>
<paragraph id="P-0098" lvl="0"><number>&lsqb;0098&rsqb;</number> Another embodiment of the instant invention involves a composition wherein the antioxidant is a phenolic antioxidant, phosphite, nitrone, amine oxide or hydroxylamine, or mixture thereof. </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> Examples of the above-embodiment are wherein the effective amount of UV absorber in combination with the oxazolidine compound and an antioxidant is 0.01 to 10% by weight based on the wax. </paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number> Another embodiment is where the effective amount of UV absorber in combination with the oxazolidine and an antioxidant is 0.1 to 2% by weight based on the wax. </paragraph>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> Still another embodiment is where the effective amount of UV absorber in combination with the oxazolidine and an antioxidant is 0.1 to 0.5% by weight based on the wax. </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> Examples of the antioxidants useful in this invention are </paragraph>
<paragraph id="P-0103" lvl="2"><number>&lsqb;0103&rsqb;</number> n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, </paragraph>
<paragraph id="P-0104" lvl="2"><number>&lsqb;0104&rsqb;</number> neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinammate), </paragraph>
<paragraph id="P-0105" lvl="2"><number>&lsqb;0105&rsqb;</number> di-n-octadecyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate, </paragraph>
<paragraph id="P-0106" lvl="2"><number>&lsqb;0106&rsqb;</number> 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, </paragraph>
<paragraph id="P-0107" lvl="2"><number>&lsqb;0107&rsqb;</number> thiodiethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </paragraph>
<paragraph id="P-0108" lvl="2"><number>&lsqb;0108&rsqb;</number> 1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, </paragraph>
<paragraph id="P-0109" lvl="2"><number>&lsqb;0109&rsqb;</number> 3,6-dioxaoctamethylene bis(3-methyl-5-tert-butyl-4-hydroxyhydrocinnamate), </paragraph>
<paragraph id="P-0110" lvl="2"><number>&lsqb;0110&rsqb;</number> 2,6-di-tert-butyl-p-cresol, </paragraph>
<paragraph id="P-0111" lvl="2"><number>&lsqb;0111&rsqb;</number> 2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol), </paragraph>
<paragraph id="P-0112" lvl="2"><number>&lsqb;0112&rsqb;</number> 1,3,5-tris(2,6-dimethyl-4-tert-butyl-3-hydroxybenzyl) isocyanurate, </paragraph>
<paragraph id="P-0113" lvl="2"><number>&lsqb;0113&rsqb;</number> 1,1,3,-tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butane, </paragraph>
<paragraph id="P-0114" lvl="2"><number>&lsqb;0114&rsqb;</number> 1,3,5-tris&lsqb;2-(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxy)ethyl&rsqb; isocyanurate, </paragraph>
<paragraph id="P-0115" lvl="2"><number>&lsqb;0115&rsqb;</number> 3,5-di-(3,5-di-tert-butyl-4-hydroxybenzyl)mesitol, </paragraph>
<paragraph id="P-0116" lvl="2"><number>&lsqb;0116&rsqb;</number> hexamethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </paragraph>
<paragraph id="P-0117" lvl="2"><number>&lsqb;0117&rsqb;</number> 1-(3,5-di-tert-butyl-4-hydroxyanilino)-3,5-di(octylthio)-s-triazine, </paragraph>
<paragraph id="P-0118" lvl="2"><number>&lsqb;0118&rsqb;</number> N,N&prime;-hexamethylene-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamamide), </paragraph>
<paragraph id="P-0119" lvl="2"><number>&lsqb;0119&rsqb;</number> calcium bis(ethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate), </paragraph>
<paragraph id="P-0120" lvl="2"><number>&lsqb;0120&rsqb;</number> ethylene bis&lsqb;3,3-di(3-tert-butyl-4-hydroxyphenyl)butyrate&rsqb;, </paragraph>
<paragraph id="P-0121" lvl="2"><number>&lsqb;0121&rsqb;</number> octyl 3,5-di-tert-butyl-4-hydroxybenzylmercaptoacetate, </paragraph>
<paragraph id="P-0122" lvl="2"><number>&lsqb;0122&rsqb;</number> bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazide, </paragraph>
<paragraph id="P-0123" lvl="2"><number>&lsqb;0123&rsqb;</number> N,N-di-(C<highlight><subscript>12</subscript></highlight>-C<highlight><subscript>24</subscript></highlight>alkyl)-N-methyl-amine oxide, or </paragraph>
<paragraph id="P-0124" lvl="2"><number>&lsqb;0124&rsqb;</number> N,N-dialkylhydroxylamine prepared from di(hydrogenated tallow)amine by direct oxidation. </paragraph>
<paragraph id="P-0125" lvl="0"><number>&lsqb;0125&rsqb;</number> Still other embodiments of antioxidants useful in the instant invention are </paragraph>
<paragraph id="P-0126" lvl="2"><number>&lsqb;0126&rsqb;</number> neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </paragraph>
<paragraph id="P-0127" lvl="2"><number>&lsqb;0127&rsqb;</number> n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, </paragraph>
<paragraph id="P-0128" lvl="2"><number>&lsqb;0128&rsqb;</number> 1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, </paragraph>
<paragraph id="P-0129" lvl="2"><number>&lsqb;0129&rsqb;</number> 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, </paragraph>
<paragraph id="P-0130" lvl="2"><number>&lsqb;0130&rsqb;</number> 2,6-di-tert-butyl-p-cresol, or </paragraph>
<paragraph id="P-0131" lvl="2"><number>&lsqb;0131&rsqb;</number> 2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol). </paragraph>
<paragraph id="P-0132" lvl="0"><number>&lsqb;0132&rsqb;</number> It should be noted that candles contain a host of various components. The base materials may be made up of the following: </paragraph>
<paragraph id="P-0133" lvl="2"><number>&lsqb;0133&rsqb;</number> paraffin wax, </paragraph>
<paragraph id="P-0134" lvl="2"><number>&lsqb;0134&rsqb;</number> natural oils, </paragraph>
<paragraph id="P-0135" lvl="2"><number>&lsqb;0135&rsqb;</number> polyamide plus fatty acid/ester, </paragraph>
<paragraph id="P-0136" lvl="2"><number>&lsqb;0136&rsqb;</number> fatty acids such as stearin, </paragraph>
<paragraph id="P-0137" lvl="2"><number>&lsqb;0137&rsqb;</number> opacifiers, </paragraph>
<paragraph id="P-0138" lvl="2"><number>&lsqb;0138&rsqb;</number> beeswax, </paragraph>
<paragraph id="P-0139" lvl="2"><number>&lsqb;0139&rsqb;</number> glycerides plus oxidized wax, </paragraph>
<paragraph id="P-0140" lvl="2"><number>&lsqb;0140&rsqb;</number> alcohols, and </paragraph>
<paragraph id="P-0141" lvl="2"><number>&lsqb;0141&rsqb;</number> ethylene oligomers. </paragraph>
<paragraph id="P-0142" lvl="0"><number>&lsqb;0142&rsqb;</number> Candles also contain a number of additives such as the following: </paragraph>
<paragraph id="P-0143" lvl="2"><number>&lsqb;0143&rsqb;</number> mold release agents, </paragraph>
<paragraph id="P-0144" lvl="2"><number>&lsqb;0144&rsqb;</number> fragrances, </paragraph>
<paragraph id="P-0145" lvl="2"><number>&lsqb;0145&rsqb;</number> insect repellants or insecticides, </paragraph>
<paragraph id="P-0146" lvl="2"><number>&lsqb;0146&rsqb;</number> hardeners, </paragraph>
<paragraph id="P-0147" lvl="2"><number>&lsqb;0147&rsqb;</number> crystal modifiers, </paragraph>
<paragraph id="P-0148" lvl="2"><number>&lsqb;0148&rsqb;</number> clarifiers, </paragraph>
<paragraph id="P-0149" lvl="2"><number>&lsqb;0149&rsqb;</number> guttering reducers, </paragraph>
<paragraph id="P-0150" lvl="2"><number>&lsqb;0150&rsqb;</number> colorants, </paragraph>
<paragraph id="P-0151" lvl="2"><number>&lsqb;0151&rsqb;</number> f.p. control agents, </paragraph>
<paragraph id="P-0152" lvl="2"><number>&lsqb;0152&rsqb;</number> stretchability improvers, </paragraph>
<paragraph id="P-0153" lvl="2"><number>&lsqb;0153&rsqb;</number> gelling agents, </paragraph>
<paragraph id="P-0154" lvl="2"><number>&lsqb;0154&rsqb;</number> extrusion aids, and </paragraph>
<paragraph id="P-0155" lvl="2"><number>&lsqb;0155&rsqb;</number> vortex reducers. </paragraph>
<paragraph id="P-0156" lvl="0"><number>&lsqb;0156&rsqb;</number> Each of the various components are meant to control or modify the properties of the candle to insure proper burning, reduce channelling, aid in uniform melting, and the like. The colorants and fragrances obviously are there to provide the proper color, scent or other aesthetic appeal. </paragraph>
<paragraph id="P-0157" lvl="0"><number>&lsqb;0157&rsqb;</number> Of increasing importance are the transparent gel candles which look like clear glass, but which burn like a classical candle. As is discussed in detail in U.S. Pat. No. 5,879,694, the relevant parts of which are incorporated herein by reference, these gel candles usually contain a copolymer selected from the group consisting of a triblock, radial block, diblock or multiblock copolymer classically made up of at least two thermodynamically incompatible segments containing both hard and soft segments. Typical of such block copolymers is KRATON&reg; (Shell Chemical Co.) which consists of block segments of styrene monomer units and rubber monomer or comonomer units. The most common structure found in KRATON&reg; D series is a linear ABA block with styrene-butadiene-styrene (SBS) or styrene-isoprene-styrene (SIS). </paragraph>
<paragraph id="P-0158" lvl="0"><number>&lsqb;0158&rsqb;</number> The following examples are meant for illustrative purposes only and are not to be construed to limit the instant invention in any manner whatsoever. </paragraph>
<paragraph id="P-0159" lvl="7"><number>&lsqb;0159&rsqb;</number> Raw Materials </paragraph>
<paragraph id="P-0160" lvl="0"><number>&lsqb;0160&rsqb;</number> Wax samples are supplied by the Candle-Lite Corporation. These samples contain dyes and fragrances. </paragraph>
<paragraph id="P-0161" lvl="0"><number>&lsqb;0161&rsqb;</number> The UV absorbers and hindered amine stabilizers are obtained from the Ciba Speciality Chemicals Corporation. </paragraph>
<paragraph id="P-0162" lvl="7"><number>&lsqb;0162&rsqb;</number> Sample Preparation </paragraph>
<paragraph id="P-0163" lvl="0"><number>&lsqb;0163&rsqb;</number> The wax samples obtained from the Candle-Lite Corporation already contain a dye and a fragrance (scent). In these cases, the wax is melted and the appropriate stabilizer(s) is (are) added and dissolved in the molten wax. The stabilized wax is then poured into five (5) 44 mm diameter aluminum pans giving five (5) wax disks. </paragraph>
<paragraph id="P-0164" lvl="7"><number>&lsqb;0164&rsqb;</number> Sample Exposure </paragraph>
<paragraph id="P-0165" lvl="0"><number>&lsqb;0165&rsqb;</number> Triplicate samples of each disk are exposed under a bank of six (6) cool-white fluorescent lamps (40 watts) or under a bank of six (6) UV lamps having a wavelength of 368 nm with the test samples being twelve (12) inches (30.48 cm) below the lamps. </paragraph>
<paragraph id="P-0166" lvl="0"><number>&lsqb;0166&rsqb;</number> Dye color fade (or color change) is measured by a Macbeth ColorEye Spectrophotometer with a 6 inch integrating sphere. The conditions are: 10 degree observer, D65 illuminant and 8 degree viewing angle. </paragraph>
<paragraph id="P-0167" lvl="0"><number>&lsqb;0167&rsqb;</number> Initial color measurements are taken using the above parameters. The L, a and b values are calculated using the CIE system from the reflectance values. YI is calculated from the L, a and b values. Subsequent measurements are taken at specified intervals. Delta L, a, b and YI values are simply the difference between the initial values and the values at each interval. Delta(&Dgr;) E is calculated as follows: </paragraph>
<paragraph lvl="0"><in-line-formula>&lsqb;(Delta <highlight><italic>L</italic></highlight>)<highlight><superscript>2</superscript></highlight>&plus;(Delta <highlight><italic>a</italic></highlight>)<highlight><superscript>2</superscript></highlight>&plus;(Delta <highlight><italic>b</italic></highlight>)<highlight><superscript>2</superscript></highlight>&rsqb;<highlight><superscript>&frac12;</superscript></highlight>&equals;Delta <highlight><italic>E. </italic></highlight></in-line-formula></paragraph>
</section>
</summary-of-invention>
<detailed-description>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
</section>
<section>
<heading lvl="1"><highlight><bold>3</bold></highlight>,<highlight><bold>3</bold></highlight>-Dimethyl-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane </heading>
<paragraph id="P-0168" lvl="0"><number>&lsqb;0168&rsqb;</number> Into a solution of 45 g (460 mmol) of cyclohexanone in 300 mL of toluene is added 35.6 g (400 mmol) of 2-amino-2,2-dimethylethanol. The reaction mixture is then heated to reflux and the by-product water is collected by a Dean-Stark trap. After 16 hours of heating at reflux, the reaction mixture is allowed to cool to ambient temperature and is then concentrated under vacuum to give 55 g of a yellow liquid. The product, identified by mass spectroscopy (m/z&equals;169),is obtained in an 81.4% yield. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr. </paragraph>
<paragraph id="P-0169" lvl="7"><number>&lsqb;0169&rsqb;</number> <highlight><superscript>1</superscript></highlight>Hnmr (CDCl<highlight><subscript>3</subscript></highlight>) (300.08 MHz) &dgr; 1.26 (s, 6H), 1.56-1.60 (m, 10H), 3.59 (s, 2H), 2.22 (s, 1H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
</section>
<section>
<heading lvl="1">2,2,4,4-Tetramethyl-1,3-oxazolidine </heading>
<paragraph id="P-0170" lvl="0"><number>&lsqb;0170&rsqb;</number> Into a 500 mL, three-necked flask with a reverse Dean-Stark trap is added 45 g (500 mmol) of 2-amino-2,2-dimethylethanol, 40 g (700 mmol) of acetone and 200 mL of methylene chloride. The reaction mixture is heated to reflux for 16 hours until no starting 2-amino-2,2-dimethylethanol is detected. The reaction mixture is allowed to cool to ambient temperature and is than concentrated under vacuum (200 mm Hg/30&deg; C.) to give 50 g (77.5% yield) of a colorless liquid. The product is identified by mass spectroscopy (m/z&equals;129) and <highlight><superscript>1</superscript></highlight>Hnmr analysis. </paragraph>
<paragraph id="P-0171" lvl="7"><number>&lsqb;0171&rsqb;</number> <highlight><superscript>1</superscript></highlight>Hnmr (CDCl<highlight><subscript>3</subscript></highlight>) (300.08 MHz) &dgr; 1.26 (s, 6H), 1.39 (s, 6H), 3.60 (s, 2H), 2.17 (s, 1H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 3 </heading>
</section>
<section>
<heading lvl="1">2,2,11,11-Tetramethyl-3,9-dioxa-dispiro(4.2.4.2&rsqb;tetradecane </heading>
<paragraph id="P-0172" lvl="0"><number>&lsqb;0172&rsqb;</number> Into a solution of 40 g (360 mmol) of 1,4-cyclohexanedione in 200 mL of toluene is added 63.5 g (720 mmol) of 2-amino-2,2-dimethylethanol. The reaction mixture is then heated to reflux and the by-product water is collected in a Dean-Stark trap. After 16 hours of heating at reflux, the reaction is allowed to cool to ambient temperature and is then concentrated under vacuum to give 91 g (98.4% yield) of a brownish wet solid. The product is identified by mass spectroscopy (m/z&equals;254) and <highlight><superscript>1</superscript></highlight>Hnmr. </paragraph>
<paragraph id="P-0173" lvl="7"><number>&lsqb;0173&rsqb;</number> <highlight><superscript>1</superscript></highlight>Hnmr (CDCl<highlight><subscript>3</subscript></highlight>) (300.08 MHz) &dgr; 1.22 (s, 12H), 1.69 (s, 4H), 1.83 (d, 4H), 3.53 (s, 4H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 4 </heading>
</section>
<section>
<heading lvl="1">Color Fade of Pink Scented Candle Wax under Fluorescent Lamp Exposure </heading>
<paragraph id="P-0174" lvl="0"><number>&lsqb;0174&rsqb;</number> A variety of different stabilizers are evaluated in pink scented candle wax obtained from the Candle-Lite Corporation under fluorescent lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>30 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>14.47&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>A (0.3%)</entry>
<entry>10.47&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>D (0.3%)</entry>
<entry>10.00&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%) &plus;</entry>
<entry>8.93</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%) &plus;</entry>
<entry>3.42</entry>
</row>
<row>
<entry></entry>
<entry>D (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>F (0.15%) &plus;</entry>
<entry>3.11</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>G (0.15%) &plus;</entry>
<entry>3.10</entry>
</row>
<row>
<entry></entry>
<entry>E (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>F (0.15%) &plus;</entry>
<entry>2.20</entry>
</row>
<row>
<entry></entry>
<entry>H (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00001">*A is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00002">B is 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 329, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00003">C is 4-octyloxy-2-hydroxybenzophenone, CHIMMASORB&thinsp;&reg; 81, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00004">D is bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, TINUVIN&thinsp;&reg; 292, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00005">E is 2-(2-hydroxy-3-&agr;-cumyl-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 928, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00006">F is 3,3-dimethyl-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, the compound of instant Example 1. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00007">G is 2,2,4,4-tetramethyl-1,3-oxazolidine, the compound of instant Example 2. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00008">H is 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-octyl/nonyl/decyloxy-2-hydroxy-propoxy)-5-&agr;-cumylphenyl&rsqb;-s-triazine. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0175" lvl="0"><number>&lsqb;0175&rsqb;</number> These data show that an oxazolidine compound (Compound F or G) in combination with a UV absorber protects the pink scented candle wax from unwanted discoloration far better than conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 5 </heading>
</section>
<section>
<heading lvl="1">Color Fade of Pink Scented Candle Wax under UV Lamp Exposure </heading>
<paragraph id="P-0176" lvl="0"><number>&lsqb;0176&rsqb;</number> A variety of different stabilizers are evaluated in pink scented candle wax obtained from the Candle-Lite Corporation under UV lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>32 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>21.10&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>D (0.3%)</entry>
<entry>16.24&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%) &plus;</entry>
<entry>11.15&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>A (0.15%) &plus;</entry>
<entry>9.84</entry>
</row>
<row>
<entry></entry>
<entry>D (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>F (0.15%) &plus;</entry>
<entry>5.97</entry>
</row>
<row>
<entry></entry>
<entry>H (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>F (0.15%) &plus;</entry>
<entry>4.73</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>G (0.15%) &plus;</entry>
<entry>2.88</entry>
</row>
<row>
<entry></entry>
<entry>E (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00009">*A is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00010">B is 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 329, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00011">C is 4-octyloxy-2-hydroxybenzophenone, CHIMMASORB&thinsp;&reg; 81, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00012">D is bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, TINUVIN&thinsp;&reg; 292, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00013">E is the reaction product of 2,4,6-tris(2,4-dihydroxyphenyl)-s-triazine with octyl &agr;-haloacetate. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00014">F is 3,3-dimethyl-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, the compound of instant Example 1. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00015">G is 2,2,4,4-tetramethyl-1,3-oxazolidine, the compound of instant Example 2. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00016">H is 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-octyl/nonyl/decyloxy-2-hydroxy-propoxy)-5-&agr;-cumylphenyl&rsqb;-s-triazine. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0177" lvl="0"><number>&lsqb;0177&rsqb;</number> These data show that an oxazolidine compound (Compound F or G) in combination with a UV absorber protects the pink scented candle wax from unwanted discoloration far better than conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 6 </heading>
</section>
<section>
<heading lvl="1">Color Fade of Gray Scented Candle Wax under Fluorescent Lamp Exposure </heading>
<paragraph id="P-0178" lvl="0"><number>&lsqb;0178&rsqb;</number> A variety of different stabilizers are evaluated in gray scented candle wax obtained from the Candle-Lite Corporation under fluorescent lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00003">
<number>3</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>24 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>16.22</entry>
</row>
<row>
<entry></entry>
<entry>A (0.3%)</entry>
<entry>10.36</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%) &plus;</entry>
<entry>&ensp;9.22</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>F (0.15%) &plus;</entry>
<entry>&ensp;6.22</entry>
</row>
<row>
<entry></entry>
<entry>H (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00017">*A is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00018">B is 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 329, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00019">C is 4-octyloxy-2-hydroxybenzophenone, CHIMMASORB&thinsp;&reg; 81, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00020">F is 3,3-dimethyl-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, the compound of instant Example 1. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00021">H is 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-octyl/nonyl/decyloxy-2-hydroxy-propoxy)-5-&agr;-cumylphenyl&rsqb;-s-triazine. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0179" lvl="0"><number>&lsqb;0179&rsqb;</number> These data show that an oxazolidine compound (Compound F) in combination with an s-triazine UV absorber protects the gray scented candle wax from unwanted discoloration far better than conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 7 </heading>
</section>
<section>
<heading lvl="1">Color Fade of Gray Scented Candle Wax under UV Lamp Exposure </heading>
<paragraph id="P-0180" lvl="0"><number>&lsqb;0180&rsqb;</number> A variety of different stabilizers are evaluated in gray scented candle wax obtained from the Candle-Lite Corporation under fluorescent lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00004">
<number>4</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="112PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>24 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>30.07</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%) &plus;</entry>
<entry>10.96</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry>G (0.15%) &plus;</entry>
<entry>&ensp;8.13</entry>
</row>
<row>
<entry></entry>
<entry>E (0.15%)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00022">B is 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 329, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00023">C is 4-octyloxy-2-hydroxybenzophenone, CHIMMASORB&thinsp;&reg; 81, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00024">E is 2-(2-hydroxy-3-&agr;-cumyl-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN &thinsp;&reg; 928, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00025">G is 2,2,4,4-tetramethyl-1,3-oxazolidine, the compound of instant Example 2. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0181" lvl="0"><number>&lsqb;0181&rsqb;</number> These data show that an oxazolidine compound (Compound G) in combination with a benzotriazole UV absorber protects the gray scented candle wax from unwanted discoloration far better than conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 8 </heading>
<paragraph id="P-0182" lvl="0"><number>&lsqb;0182&rsqb;</number> Green scented candle wax is well stabilized by 0.2% by weight of dimethyl p-methoxybenzylidenemalonate, SANDUVOR&reg; PR 25, in combination with 0.2% by weight of 3,3-dimethyl-l-oxa-4-azaspiro&lsqb;4.5&rsqb;decane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 9 </heading>
<paragraph id="P-0183" lvl="0"><number>&lsqb;0183&rsqb;</number> Yellow scented candle wax is well stabilized by 0.1% by weight of di( 1,2,2,6,6-penta methylpiperidin-4-yl) p-methoxybenzylidenemalonate, SANDUVOR&reg; PR31, in combination with 0.1% by weight of 2,2,4,4-tetramethyl-1,3-oxazolidine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 10 </heading>
<paragraph id="P-0184" lvl="0"><number>&lsqb;0184&rsqb;</number> Red unscented candle wax is well stabilized by 0.1% by weight of dimethyl di(p-chlorophenyl)methylenemalonate in combination with 0.1% by weight of 2,2,11,11-tetramethyl-3,9-dioxa-dispiro(<highlight><bold>4.2.4.2&rsqb;tetradecane. </bold></highlight></paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 11 </heading>
<paragraph id="P-0185" lvl="0"><number>&lsqb;0185&rsqb;</number> Red unscented candle wax is well stabilized by 0.2% by weight of dimethyl di(p-methoxyphenyl)methylenemalonate in combination with 0.2% by weight of 3,3-dimethyl-1-oxa-4-oxyl-4-azaspiro&lsqb;4.5&rsqb;decane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 12 </heading>
<paragraph id="P-0186" lvl="0"><number>&lsqb;0186&rsqb;</number> Red unscented candle wax is well stabilized by 0.1% by weight of 4,4&prime;-dimethoxy-2,2&prime;-dihydroxybenzophenone in combination with 0.1% by weight of 3,3-dimethyl-1-oxa-4-hydroxy-4-azaspiro&lsqb;4.5&rsqb;decane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 13 </heading>
<paragraph id="P-0187" lvl="0"><number>&lsqb;0187&rsqb;</number> Red unscented candle wax is well stabilized by 0.2% by weight of 4-tert-butyl-phenyl 2-hydroxybenzoate in combination with 0.1% by weight of 3,3-dimethylol-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 14 </heading>
<paragraph id="P-0188" lvl="0"><number>&lsqb;0188&rsqb;</number> Yellow unscented candle wax is well stabilized by 0.2% by weight of 2-ethoxy-2-ethyloxanilide in combination with 0.1% by weight of 2,3,3-trimethyl-1-oxa-4-azaspiro-&lsqb;4.5&rsqb;decane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 15 </heading>
<paragraph id="P-0189" lvl="0"><number>&lsqb;0189&rsqb;</number> Yellow unscented candle wax is well stabilized by 0.2% by weight of 3-hydroxy-phenyl benzoate in combination with 0.2% by weight of 3,3-di(2-hydroxyethyl)-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 16 </heading>
<paragraph id="P-0190" lvl="0"><number>&lsqb;0190&rsqb;</number> Blue unscented candle wax is well stabilized by 0.2% by weight of dodecyl 3-phenyl-3-methyl-&agr;-cyanoacrylate in combination with 0.1% by weight of 4-ethyl-2-isopropyloxazolidine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 17 </heading>
<paragraph id="P-0191" lvl="0"><number>&lsqb;0191&rsqb;</number> Blue unscented candle wax is well stabilized by 0.2% by weight of dodecyl 3,3-diphenyl-&agr;-cyanoacrylate in combination with 0.2% by weight of 1-aza-3,7-dioxa-2,8-diisopropyl-5-ethylbicyclo&lsqb;3.3.0&rsqb;octane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 18 </heading>
<paragraph id="P-0192" lvl="0"><number>&lsqb;0192&rsqb;</number> Yellow scented candle wax is well stabilized by 0.2% by weight of 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy)carbonyl)ethyl&rsqb;phenyl&rcub;-2H-benzo-triazole, <highlight><bold>7</bold></highlight> TINUVIN&reg; 1130, CIBA, in combination with 2% by weight of 3-acetyl-4,4-dimethyl-2-(3-amyl)oxazolidine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 19 </heading>
<paragraph id="P-0193" lvl="0"><number>&lsqb;0193&rsqb;</number> Yellow scented candle wax is well stabilized by 0.1% by weight of 2-&lsqb;2-hydroxy-3-(+<highlight><bold>60</bold></highlight>, &agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole, TINUVIN&reg; 928, CIBA, in combination with 0.2% by weight of 3-acetyl-4-ethyl-2-phenyloxazolidine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 20 </heading>
<paragraph id="P-0194" lvl="0"><number>&lsqb;0194&rsqb;</number> Red scented candle wax is well stabilized by 0.1% by weight of 5-chloro-2-(2-hydroxy-3-tert-butyl-5-methylphenyl)-2H-benzotriazole, TINUVIN&reg; 326, CIBA, in combination with 0.1% by weight of N-(2-hydroxyethyl)-2,2&prime;-diethyl-4,4&prime;-dimethyl-1,3-oxazolidine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 21 </heading>
<paragraph id="P-0195" lvl="0"><number>&lsqb;0195&rsqb;</number> Green scented candle wax is well stabilized by 0.1% by weight of octyl 3-(benzo-triazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&reg; 384, CIBA, in combination with 0.1% by weight of 1-aza-3,7-dioxa-2,8-diphenyl-5-methylolbicylo-&lsqb;3.3.0&rsqb;octane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 22 </heading>
<paragraph id="P-0196" lvl="0"><number>&lsqb;0196&rsqb;</number> Green scented candle wax is well stabilized by 0.1% by weight of octyl 3-(benzo-triazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&reg; 384, CIBA, in combination with 0.1% by weight of 1-aza-3,7-dioxa-2,8-di-n-propyl-5-methylolbicyclo-&lsqb;3.3.0&rsqb;octane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 23 </heading>
<paragraph id="P-0197" lvl="0"><number>&lsqb;0197&rsqb;</number> Blue scented candle wax is well stabilized by 0.1% by weight of 2-(2-hydroxy-5-tert-octylphenyl-2H-benzotriazole, TINUVIN&reg; 329, CIBA, in combination with 0.1% by weight of 3,3-dimethyl-1-oxa-4-hydroxy-4-azaspiro&lsqb;4.5&rsqb;decane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 24 </heading>
<paragraph id="P-0198" lvl="0"><number>&lsqb;0198&rsqb;</number> Blue scented candle wax is well stabilized by 0.2% by weight of 4-octyloxy-2-hydroxybenzophenone in combination with 0.1% by weight of 3,3-dimethyl-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 25 </heading>
<paragraph id="P-0199" lvl="0"><number>&lsqb;0199&rsqb;</number> Red unscented candle wax is well stabilized by 0.2% by weight of 2-ethylhexyl p-methoxycinnamate in combination with 0.1% by weight of 2,2,4,4-tetramethyl-1,3-oxazolidine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 26 </heading>
<paragraph id="P-0200" lvl="0"><number>&lsqb;0200&rsqb;</number> Red unscented candle wax is well stabilized by 0.1% by weight of 4,4&prime;-dimethoxy-2,2&prime;dihydroxybenzophenone in combination with 0.1% by weight of 1-aza-3,7-dioxa-2,8-di-n-propyl-5-methylolbicyclo&lsqb;3.3.0&rsqb;octane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 27 </heading>
<paragraph id="P-0201" lvl="0"><number>&lsqb;0201&rsqb;</number> Yellow unscented candle wax is well stabilized by 0.1% by weight of 2-ethoxy-2&prime;-ethyl-5,4&prime;-di-tert-butyloxanilide in combination with 0.1% by weight of 2,2,11,11-tetra-methyl-3,9-dioxa-dispiro(4.2.4.2&rsqb;tetradecane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 28 </heading>
<paragraph id="P-0202" lvl="0"><number>&lsqb;0202&rsqb;</number> Yellow unscented candle wax is well stabilized by 0.1% by weight of 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy)-phenyl&rsqb;-s-triazine, TINUVIN&reg; 400, CIBA, in combination with 0.1% by weight of 3-acetyl-4,4-dimethyl-2-(3-amyl)oxazolidine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 29 </heading>
<paragraph id="P-0203" lvl="0"><number>&lsqb;0203&rsqb;</number> Blue scented candle wax is well stabilized by 0.1% by weight of 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy)-5-&agr;-cumylphenyl&rsqb;-s-triazine in combination with 0.1% by weight of 4-ethyl-2-isopropyl-oxazolidine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 30 </heading>
<paragraph id="P-0204" lvl="0"><number>&lsqb;0204&rsqb;</number> Blue unscented candle wax is well stabilized by 0.2% by weight of 2,4-bis-(2,4-dimethylphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine in combination with 0.1% by weight of 1-acetyl-2,2,6,6-tetramethyl-4,4-(1-oxa-2,4-dioxo-3-dodecylimino-tetramethylene)piperidine, TINUVIN&reg; 440, CIBA, and 0.1% by weight of 1-aza-3,7-dioxa-2,8-di-n-propyl-5-methylolibicyclo&lsqb;3.3.0&rsqb;octane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 31 </heading>
<paragraph id="P-0205" lvl="0"><number>&lsqb;0205&rsqb;</number> Blue unscented candle wax is well stabilized by 0.1% by weight of 2,4-bis(2,4-dimethylphenyl-6-&lsqb;2-hydroxy-4-(3-do-/tri-decloxy-2-hydroxypropoxy)-phenyl&rsqb;-s-triazine, TINUVIN&reg; 400, CIBA, in combination with 0.1% by weight of bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, TINUVIN&reg; 292, CIBA, and 0.1% by weight of 2,2,4,4-tetramethyl-1,3-oxazolindine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 32 </heading>
<paragraph id="P-0206" lvl="0"><number>&lsqb;0206&rsqb;</number> White unscented candle wax is well stabilized by 0.1% by weight of 4-tert-octyl-phenyl2-hydroxybenzoate in combination with 2% by weight of 2,2,11,11-tetramethyl-3,9-dioxa-dispiro(4.2.4.2&rsqb;tetradecane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 33 </heading>
<paragraph id="P-0207" lvl="0"><number>&lsqb;0207&rsqb;</number> White unscented candle wax is well stabilized by 0.1% by weight of 3-hydroxy-phenyl benzoate in combination with 0.1% by weight of octyl 3-(benzotriazol-2yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&reg; 384, CIBA, and 0.1% by weight of 3,3-dimethyl-1-oxa-4-hydroxy-4-azaspiro&lsqb;4.5&rsqb;decane. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 34 </heading>
<paragraph id="P-0208" lvl="0"><number>&lsqb;0208&rsqb;</number> Yellow scented candle wax is well stabilized by 0.1% by weight of dodecyl 3,3-diphenyl-&agr;-cyanoacrylate in combination with 0.1% by weight of 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy)-phenyl&rsqb;-s-triazine, TINUVIN&reg; 400, CIBA, and 0.1% by weight of 2,2,4,4-tetramethyl-1,3-oxazolidine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 35 </heading>
<paragraph id="P-0209" lvl="0"><number>&lsqb;0209&rsqb;</number> Yellow scented candle wax is well stabilized by 0.1% by weight of pentaerythrityl tetrakis&lsqb;3,3-diphenyl-&agr;-cyanoacrylate&rsqb; in combination with 0.2% by weight of 3-acetyl-4-ethyl-2-phenyloxazolidine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 36 </heading>
<paragraph id="P-0210" lvl="0"><number>&lsqb;0210&rsqb;</number> Red scented candle wax is well stabilized by 0.2% by weight of octyl 3-(p-methoxyphenyl)-3-phenyl-&agr;-cyanoacrylate in combination with 0.2% by weight of 1-aza-3,7-dioxa-2,8-diphenyl-5-methylolbicyclo&lsqb;3.3.0&rsqb;octane. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A composition which comprises 
<claim-text>(a) candle wax which is white and unscented; white and scented; dyed and unscented; dyed and scented; dipped and unscented; or dipped and scented, and </claim-text>
<claim-text>(b) an effective stabilizing amount of a combination of 
<claim-text>(i) an oxazolidine compound containing a moiety of generic formula I, II or III </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00003">
<number>3</number>
<image id="EMI-C00003" he="281.0619" wi="169.22115" file="US20030000128A1-20030102-C00003.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00003" file="US20030000128A1-20030102-C00003.CDX"/>
<chemistry-mol-file id="CHEMMOL-00003" file="US20030000128A1-20030102-C00003.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>(ii) a UV absorber or an antioxidant, or a UV absorber and an antioxidant </claim-text>
</claim-text>
<claim-text>wherein the ratio by weight of (i) to (ii) is from 10:1 to 1:10. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the oxazolidine compound of component (b)(i) is a compound of formula Ia, IIa or IIIa </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00004">
<number>4</number>
<image id="EMI-C00004" he="268.3611" wi="175.23135" file="US20030000128A1-20030102-C00004.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00004" file="US20030000128A1-20030102-C00004.CDX"/>
<chemistry-mol-file id="CHEMMOL-00004" file="US20030000128A1-20030102-C00004.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>where 
<claim-text>R<highlight><subscript>1</subscript></highlight>, R<highlight><subscript>2</subscript></highlight>, R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>are independently alkyl of 1 to 8 carbon atoms, or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together or R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>together are tetramethylene, pentamethylene or pentamethylene substituted by methyl; </claim-text>
<claim-text>R<highlight><subscript>5 </subscript></highlight>is hydrogen, oxyl, hydroxyl, aralkyl of 7 to 15 carbon atoms, alkoxy of 1 to 24 carbon atoms, alkyl of 1 to 42 carbon atoms, said alkyl substituted by one or two hydroxyl groups, said alkyl substituted by alkylcarbonyloxy of 2 to 18 carbon atoms, or said alkyl interrupted by one to twenty oxygen atoms and substituted by one hydroxyl, by alkylcarbonyloxy of 2 to 18 carbon atoms or by 4-hydroxy-3,5-di-tert-butylbenzoyloxy; or R<highlight><subscript>5 </subscript></highlight>is &mdash;CO&mdash;C<highlight><subscript>n</subscript></highlight>H<highlight><subscript>2n&plus;1 </subscript></highlight>where n is 1 to 17, and </claim-text>
<claim-text>R<highlight><subscript>6 </subscript></highlight>is alkyl of 1 to 8 carbon atoms, said alkyl substituted by one or two hydroxyl groups, or is aryl of 6 to 10 carbon atoms. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference> where in the compound of formula Ia, IIa or IIIa, R<highlight><subscript>1</subscript></highlight>, R<highlight><subscript>2</subscript></highlight>, R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>are each methyl, or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together and R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>4 </subscript></highlight>together are pentamethylene. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the oxazolidine compound of formula Ia, IIa or IIIa is 
<claim-text>(a) 3,3-dimethyl-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, </claim-text>
<claim-text>(b) 2,2,4,4-tetramethyl-1,3-oxazolidine, </claim-text>
<claim-text>(c) 2,2,11,11-tetramethyl-3,9-dioxa-dispiro(4.2.4.2&rsqb;tetradecane, </claim-text>
<claim-text>(d) 3,3-dimethyl-1-oxa-4-oxyl-4-azaspiro&lsqb;4.5&rsqb;decane, </claim-text>
<claim-text>(e) 3,3-dimethyl-1-oxa-4-hydroxy-4-azaspiro&lsqb;4.5&rsqb;decane, </claim-text>
<claim-text>(f) 3,3-dimethylol-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, </claim-text>
<claim-text>(g) 2,3,3-trimethyl-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, </claim-text>
<claim-text>(h) 3,3-di(2-hydroxyethyl)-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, </claim-text>
<claim-text>(i) 4-ethyl-2-isopropyloxazolidine, </claim-text>
<claim-text>(j) 1-aza-3,7-dioxa-2,8-diisopropyl-5-ethylbicyclo&lsqb;3.3.0&rsqb;octane, </claim-text>
<claim-text>(k) 3-acetyl-4,4-dimethyl-2-(3-amyl)oxazolidine, </claim-text>
<claim-text>(l) 3-acetyl-4-ethyl-2-phenyloxazolidine, </claim-text>
<claim-text>(m) N-(2-hydroxyethyl)-2,2&prime;-diethyl-4,4&prime;-dimethyl-1,3-oxazolidine, </claim-text>
<claim-text>(n) 1-aza-3,7-dioxa-2,8-diphenyl-5-methylolbicyclo&lsqb;3.3.0&rsqb;octane, or </claim-text>
<claim-text>(o) 1-aza-3,7-dioxa-2,8-di-n-propyl-5-methylolbicyclo&lsqb;3.3.0&rsqb;octane. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> wherein the oxazolidine compound is 
<claim-text>(a) 3,3-dimethyl-1-oxa-4-azaspiro&lsqb;4.5&rsqb;decane, </claim-text>
<claim-text>(b) 2,2,4,4-tetramethyl-1,3-oxazolidine, or </claim-text>
<claim-text>(c) 2,2,11,11-tetramethyl-3,9-dioxa-dispiro(4.2.4.2&rsqb;tetradecane. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the ratio by weight of (i) to (ii) is from 4:1 to 1:4. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> wherein the ratio by weight of (i) to (ii) is from 2:1 to 1:2. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the effective amount of the UV absorber plus the oxazolidine compound in the candle wax is 0.01 to 10% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00008">claim 8</dependent-claim-reference> wherein the effective amount of the UV absorber plus oxazolidine in the candle wax is 0.1 to 2% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference> wherein the effective amount of the UV absorber plus oxazolidine in the candle wax is 0.1 to 0.5% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the UV absorber of component (ii) is a benzotriazole, a benzophenone, an &agr;-cyanoacrylate, an oxanilide, an s-triazine, a cinnamate, a malonate, a benzoate or a salicylate, or a mixture thereof. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference> wherein the UV absorber is a benzotriazole, a benzophenone or an s-triazine. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 12</dependent-claim-reference> wherein the UV absorber is 
<claim-text>(a) 4-octyloxy-2-hydroxybenzophenone; </claim-text>
<claim-text>(b) 4-methoxy-2-hydroxybenzophenone; </claim-text>
<claim-text>(c) 2-(2-hydroxy-5-methylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(d) 2-(2-hydroxy-5-tert-octylphenyl-2H-benzotriazole; </claim-text>
<claim-text>(e) 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(f) octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate; </claim-text>
<claim-text>(g) 2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(h) 2-(2-hydroxy-5-tert-butylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(i) 5-chloro-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(j) 5-chloro-2-(2-hydroxy-3-tert-butyl-5-methylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(k) 2-(2-hydroxy-3-sec-butyl-5-tert-butylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(l) 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(m) 2-(2-hydroxy-3-dodecyl-5-methylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(n) 2-&lsqb;2-hydroxy-3,5-di(&agr;,&agr;-dimethylbenzyl)phenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(o) 2-&lsqb;2-hydroxy-3-(&agr;,&agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(p) 2- &lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy)carbonyl)-ethyl&rsqb;phenyl&rcub;-2H-benzotriazole; </claim-text>
<claim-text>(q) 2- &lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(octyloxy)carbonyl)ethyl&rsqb;phenyl&rcub;-2H-benzo-triazole. </claim-text>
<claim-text>(r) 2-ethylhexyl p-methoxycinnamate; </claim-text>
<claim-text>(s) 4-methoxy-2,2&prime;-dihydroxybenzophenone; </claim-text>
<claim-text>(t) 4,4&prime;dimethoxy-2,2&prime;-dihydroxybenzophenone; </claim-text>
<claim-text>(u) 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine; </claim-text>
<claim-text>(v) 2,4-diphenyl-6-(2-hydroxy-4-hexyloxyphenyl)-s-triazine; </claim-text>
<claim-text>(w) 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxy-propoxy)phenyl&rsqb;-s-triazine; (x) 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decloxy-2-hydroxypropoxy)-5-&agr;-cumylphenyl&rsqb;-s-triazine; </claim-text>
<claim-text>(y) reaction product of 2,4,6-tris(2,4-dihydroxyphenyl)-s-triazine with octyl &agr;-haloacetate; or </claim-text>
<claim-text>(z) the mixture of 3,3;3,5;5,5-methylene-bis&lsqb;2,4-bis(2,4-dimethyl-phenyl)&rsqb;-6-&lsqb;2-hydroxy-4-(3-butyloxy-2-hydroxypropoxyphenyl)&rsqb;-s-triazine. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> wherein the UV absorber is 
<claim-text>(a) 4-octyloxy-2-hydroxybenzophenone; </claim-text>
<claim-text>(b) 4-methoxy-2-hydroxybenzophenone; </claim-text>
<claim-text>(d) 2-(2-hydroxy-5-tert-octylphenyl-2H-benzotriazole; </claim-text>
<claim-text>(o) 2-&lsqb;2-hydroxy-3-(&agr;,&agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(p) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy)carbonyl)-ethyl&rsqb;phenyl&rcub;-2H-benzotriazole; </claim-text>
<claim-text>(q) 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(octyloxy)carbonyl)ethyl&rsqb;phenyl &rcub;-2H- benzo-triazole; </claim-text>
<claim-text>(y) reaction product of 2,4,6-tris(2,4-dihydroxyphenyl)-s-triazine with octyl &agr;-haloacetate; or </claim-text>
<claim-text>(z) the mixture of 3,3;3,5;5,5-methylene-bis&lsqb;2,4-bis(2,4-dimethyl-phenyl)&rsqb;-6-&lsqb;2-hydroxy-4-(3-butyloxy-2-hydroxypropoxyphenyl)&rsqb;-s-triazine. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the composition also contains an antioxidant. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 15</dependent-claim-reference> wherein the antioxidant is a phenolic antioxidant, phosphite, nitrone, amine oxide or hydroxylamine, or mixture thereof. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the effective amount of UV absorber in combination with the oxazolidine and an antioxidant is 0.01 to 10% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference> wherein the effective amount of UV absorber in combination with the oxazolidine and an antioxidant is 0.1 to 2% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 18</dependent-claim-reference> wherein the effective amount of UV absorber in combination with the oxazolidine and an antioxidant is 0.1 to 0.5% by weight based on the wax. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 15</dependent-claim-reference> wherein the antioxidant is 
<claim-text>n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, </claim-text>
<claim-text>neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinammate), </claim-text>
<claim-text>di-n-octadecyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate, </claim-text>
<claim-text>1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, </claim-text>
<claim-text>thiodiethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </claim-text>
<claim-text>1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, </claim-text>
<claim-text>3,6-dioxaoctamethylene bis(3-methyl-5-tert-butyl-4-hydroxyhydrocinnamate), </claim-text>
<claim-text>2,6-di-tert-butyl-p-cresol, </claim-text>
<claim-text>2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol), </claim-text>
<claim-text>1,3,5-tris(2,6-dimethyl-4-tert-butyl-3-hydroxybenzyl) isocyanurate, </claim-text>
<claim-text>1,1,3,-tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butane, </claim-text>
<claim-text>1,3,5-tris&lsqb;2-(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxy)ethyl&rsqb; isocyanurate, </claim-text>
<claim-text>3,5-di-(3,5-di-tert-butyl-4-hydroxybenzyl)mesitol, </claim-text>
<claim-text>hexamethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </claim-text>
<claim-text>1-(3,5-di-tert-butyl-4-hydroxyanilino)-3,5-di(octylthio)-s-triazine, </claim-text>
<claim-text>N,N&prime;-hexamethylene-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamamide), </claim-text>
<claim-text>calcium bis(ethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate), </claim-text>
<claim-text>ethylene bis&lsqb;3,3-di(3-tert-butyl-4-hydroxyphenyl)butyrate&rsqb;, </claim-text>
<claim-text>octyl 3,5-di-tert-butyl-4-hydroxybenzylmercaptoacetate, </claim-text>
<claim-text>bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazide, </claim-text>
<claim-text>N,N&prime;-bis&lsqb;2-(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxy)-ethyl&rsqb;oxamide, </claim-text>
<claim-text>N,N-di-(C<highlight><subscript>14</subscript></highlight>-C<highlight><subscript>24</subscript></highlight>alkyl)-N-methylamine oxide, or </claim-text>
<claim-text>N,N-dialkylhydroxylamine prepared from di(hydrogenated tallow)amine by direct oxidation. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. A composition according to claim <highlight><bold>20</bold></highlight> wherein the antioxidant is 
<claim-text>neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), </claim-text>
<claim-text>n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, </claim-text>
<claim-text>1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, </claim-text>
<claim-text>1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, </claim-text>
<claim-text>2,6-di-tert-butyl-p-cresol, or </claim-text>
<claim-text>2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol).</claim-text>
</claim-text>
</claim>
</subdoc-claims>
</patent-application-publication>
